Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic SCT (HSCT) is recognized as a new-onset obstructive lung defect (OLD) in pulmonary function testing and is related to pulmonary chronic GVHD. Little is known about the different phenotypes of patients with BOS and their outcomes....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Bergeron, A, Godet, C, Chevret, S, Lorillon, G, Peffault de Latour, R, de Revel, T, Robin, M, Ribaud, P, Socié, G, Tazi, A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7091913/
https://ncbi.nlm.nih.gov/pubmed/23208317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.241
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars